MedPath

A Clinical Trial To Study The Effect Of Guggulu Vati In Vatarakta (Gouty Arthritis)

Phase 2/3
Not yet recruiting
Conditions
Gout, unspecified. Ayurveda Condition: VATARAKTAM,
Registration Number
CTRI/2025/06/088466
Lead Sponsor
Sdm Ayurveda College Hospital And Research Center
Brief Summary

This is an open label randomised controlled clinical trial to evaluate the effect of Guggulu vati in the management of Gouty Arthritis w.s.r to Gouty Arthritis and also compare it with the standard drug,kaishora guggulu for a period of intervention of 30 days with primary outcomes as Serum uric acid and secondary outcome as Sandhi shoola (pain in joints) ,Sandhi shotha(swelling in joints) , Sparsha asahyata(tenderness) ,Raga(discolouration).

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria
  • 1.Serum uric acid level 7 mg/dL -30 mg/dL in male and 5.7.
  • 30 mg/dL in female. 2.Clinical features of Vatarakta such as Sandhi soola and Sandhi shotha ,pertaining to smaller joints especially joints of toe and digits of hand.
Exclusion Criteria

Pregnancy and lactation period.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum uric acid0 th and 30 th day
Secondary Outcome Measures
NameTimeMethod
1.Sandhi shoola.(Pain in joints)2.Sandhi shotha (Swelling in joints)

Trial Locations

Locations (1)

Sdm Ayurveda College,Hospital And Research Center

🇮🇳

Udupi, KARNATAKA, India

Sdm Ayurveda College,Hospital And Research Center
🇮🇳Udupi, KARNATAKA, India
Dr Amritha P
Principal investigator
8848908793
amrithapmenon@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.